pre-IPO PHARMA

COMPANY OVERVIEW

Tmunity is inventing the future of cell therapy–today–by integrating and leveraging all the talent, tools and insights required to accelerate the availability of new T cell therapies to patients.


LOCATION

  • Philadelphia, PA, USA

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Oncology

  • WEBSITE

    https://www.tmunity.com/


    CAREER WEBSITE

    https://www.tmunity.com/careers


    SOCIAL MEDIA


    INVESTORS

    be-the-match-biotherapies gilead kleiner-perkins lilly-asia-ventures parker-institute pingan-ventures university-pennsylvania westlake-villiage-biopartners


    PRESS RELEASES


    Feb 22, 2023

    Kite Completes Acquisition of Tmunity


    Dec 20, 2022

    Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer


    Feb 9, 2021

    Tmunity Therapeutics Announces Expansion of T Cell Engineered Therapy Collaboration


    Jan 25, 2021

    Tmunity Announces Appointment of Jeffrey Leiden M.D., Ph.D. as Chairman of the Board of Directors


    Jan 5, 2021

    Tmunity to Present at the 39th Annual J.P. Morgan Healthcare Conference


    For More Press Releases


    Google Analytics Alternative